ZBP1 Drives IAV-Induced NLRP3 Inflammasome Activation and Lytic Cell Death, PANoptosis, Independent of the Necroptosis Executioner MLKL.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
24 Oct 2023
Historique:
received: 04 10 2023
revised: 20 10 2023
accepted: 21 10 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Influenza A virus (IAV) continues to pose a significant global health threat, causing severe respiratory infections that result in substantial annual morbidity and mortality. Recent research highlights the pivotal role of innate immunity, cell death, and inflammation in exacerbating the severity of respiratory viral diseases. One key molecule in this process is ZBP1, a well-recognized innate immune sensor for IAV infection. Upon activation, ZBP1 triggers the formation of a PANoptosome complex containing ASC, caspase-8, and RIPK3, among other molecules, leading to inflammatory cell death, PANoptosis, and NLRP3 inflammasome activation for the maturation of IL-1β and IL-18. However, the role for other molecules in this process requires further evaluation. In this study, we investigated the role of MLKL in regulating IAV-induced cell death and NLRP3 inflammasome activation. Our data indicate IAV induced inflammatory cell death through the ZBP1-PANoptosome, where caspases and RIPKs serve as core components. However, IAV-induced lytic cell death was only partially dependent on RIPK3 at later timepoints and was fully independent of MLKL throughout all timepoints tested. Additionally, NLRP3 inflammasome activation was unaffected in MLKL-deficient cells, establishing that MLKL and MLKL-dependent necroptosis do not act upstream of NLRP3 inflammasome activation, IL-1β maturation, and lytic cell death during IAV infection.

Identifiants

pubmed: 38005819
pii: v15112141
doi: 10.3390/v15112141
pmc: PMC10674287
pii:
doi:

Substances chimiques

Inflammasomes 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
MLKL protein, human EC 2.7.-
Protein Kinases EC 2.7.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R35 CA253095
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI101935
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124346
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI101935
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI160179
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR056296
Pays : United States

Références

Trends Microbiol. 2017 Sep;25(9):713-728
pubmed: 28734617
Vaccine. 2010 Jul 12;28(31):4895-902
pubmed: 20553769
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
Cold Spring Harb Perspect Med. 2021 Apr 1;11(4):
pubmed: 31964651
Nature. 2016 Dec 1;540(7631):129-133
pubmed: 27819682
Nat Rev Microbiol. 2011 Jul 11;9(8):590-603
pubmed: 21747392
Nature. 2006 Oct 5;443(7111):578-81
pubmed: 17006449
Gastroenterology. 2019 Jan;156(1):275-278
pubmed: 30267714
J Biol Chem. 2020 Dec 25;295(52):18276-18283
pubmed: 33109609
N Engl J Med. 2013 May 16;368(20):1888-97
pubmed: 23577628
J Exp Med. 1941 Jan 1;73(1):43-55
pubmed: 19871064
Viruses. 2020 Apr 04;12(4):
pubmed: 32260457
Curr Opin Immunol. 2023 Aug;83:102348
pubmed: 37267644
Science. 2018 Aug 24;361(6404):810-813
pubmed: 30026316
Clin Transl Med. 2023 Sep;13(9):e1409
pubmed: 37700491
Immunity. 2013 Sep 19;39(3):443-53
pubmed: 24012422
Immunity. 2022 Mar 8;55(3):423-441.e9
pubmed: 35139355
Sci Immunol. 2022 Aug 26;7(74):eabo6294
pubmed: 35587515
Nature. 2006 Mar 9;440(7081):233-6
pubmed: 16407888
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Lancet Infect Dis. 2014 Jan;14(1):57-69
pubmed: 24239327
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32797196
Viral Immunol. 2011 Apr;24(2):77-88
pubmed: 21449718
Nature. 2014 Aug 7;512(7512):69-73
pubmed: 25043000
Nat Med. 2006 Oct;12(10):1203-7
pubmed: 16964257
Nature. 2008 Feb 7;451(7179):725-9
pubmed: 18256672
Nat Protoc. 2020 Oct;15(10):3284-3333
pubmed: 32895525
Cell Host Microbe. 2016 Jul 13;20(1):13-24
pubmed: 27321907
Front Immunol. 2022 Nov 24;13:1068230
pubmed: 36505497
Trends Immunol. 2021 Aug;42(8):681-705
pubmed: 34217595
Immunity. 2020 Jun 16;52(6):978-993.e6
pubmed: 32362323
Cell. 2020 Apr 30;181(3):674-687.e13
pubmed: 32298652
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:26-33
pubmed: 24034480
Nature. 2016 Dec 1;540(7631):124-128
pubmed: 27819681
Mol Cell Biol. 2004 Feb;24(4):1464-9
pubmed: 14749364
Immunity. 2009 Apr 17;30(4):566-75
pubmed: 19362023
Nature. 2020 Apr;580(7803):391-395
pubmed: 32296175
mBio. 2023 Apr 25;14(2):e0011023
pubmed: 36852999
Nature. 2011 Mar 17;471(7338):363-7
pubmed: 21368763
Crit Care Med. 2009 May;37(5):1594-603
pubmed: 19325471
Cell Host Microbe. 2016 Nov 9;20(5):674-681
pubmed: 27746097
Biomed J. 2018 Aug;41(4):218-233
pubmed: 30348265
Immunol Rev. 2020 Sep;297(1):26-38
pubmed: 32729116
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):970-975
pubmed: 30591564
J Immunol. 2022 Nov 1;209(9):1625-1633
pubmed: 36253067
Front Immunol. 2015 Jul 20;6:361
pubmed: 26257731
Sci Immunol. 2016 Aug 5;1(2):
pubmed: 27917412
Nature. 2020 Apr;580(7803):386-390
pubmed: 32296174
Front Cell Infect Microbiol. 2019 Nov 26;9:406
pubmed: 31850239
Cell. 2020 Mar 19;180(6):1115-1129.e13
pubmed: 32200799
J Infect Dis. 2010 Oct 15;202(8):1161-70
pubmed: 20815704
N Engl J Med. 2005 Sep 29;353(13):1374-85
pubmed: 16192482
J Virol. 2010 Aug;84(15):7569-80
pubmed: 20504924
Cell. 2022 Aug 18;185(17):3214-3231.e23
pubmed: 35907404
Nat Commun. 2023 May 29;14(1):3082
pubmed: 37248261
Cell. 2021 Jan 7;184(1):149-168.e17
pubmed: 33278357
Nat Cell Biol. 2019 Jun;21(6):731-742
pubmed: 31086261
Immunohorizons. 2021 Jul 21;5(7):568-580
pubmed: 34290111
J Infect Dis. 2016 Apr 1;213(7):1180-8
pubmed: 26597256
J Exp Med. 2017 Aug 7;214(8):2217-2229
pubmed: 28634194
Immunity. 2015 Jan 20;42(1):55-67
pubmed: 25607459

Auteurs

R K Subbarao Malireddi (RKS)

Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA.

Bhesh Raj Sharma (BR)

Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA.

Ratnakar R Bynigeri (RR)

Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA.

Yaqiu Wang (Y)

Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA.

Jianlin Lu (J)

Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA.

Thirumala-Devi Kanneganti (TD)

Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH